XML 32 R21.htm IDEA: XBRL DOCUMENT v3.7.0.1
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Dec. 31, 2016
Antidilutive Securities Excluded and Imapirment charges          
Revenue percentage     100.00% 100.00%  
Research and development costs $ 46,732 $ 46,730 $ 94,389 $ 104,455  
Fair value of notes $ (30,000)   $ (30,000)    
Warrants exercisable shares 4,175,000   4,175,000   4,175,000
Weighted average common shares outstanding 31,750,106 31,750,106 31,750,106 31,750,106